101 – 143 of 143
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2015
-
Mark
Fall-related activity avoidance in people ageing with Parkinson’s disease
2015) 68th Annual Scientific Meeting of the Gerontological Society of America(
- Contribution to conference › Abstract
-
Mark
Improvement of dyskinesias with l-dopa infusion in advanced Parkinson's disease.
2015) In Acta Neurologica Scandinavica(
- Contribution to journal › Article
-
Mark
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
(
- Contribution to journal › Article
-
Mark
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
(
- Contribution to journal › Article
-
Mark
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
(
- Contribution to journal › Scientific review
-
Mark
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.
(
- Contribution to journal › Article
-
Mark
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system.
(
- Contribution to journal › Article
-
Mark
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
(
- Contribution to journal › Article
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study.
(
- Contribution to journal › Article
-
Mark
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
(
- Contribution to journal › Article
- 2013
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
(
- Contribution to journal › Article
-
Mark
Reduced Body Mass Index in Parkinson's Disease: Contribution of Comorbid Depression.
(
- Contribution to journal › Article
-
Mark
A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
(
- Contribution to journal › Article
-
Mark
Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.
(
- Contribution to journal › Article
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
-
Mark
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
(
- Contribution to journal › Article
- 2012
-
Mark
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects.
(
- Contribution to journal › Article
-
Mark
Duration of L-dopa and dopamine agonist monotherapy in Parkinson´s disease
(
- Contribution to journal › Article
-
Mark
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Article
- 2011
-
Mark
Levodopa--carbidopa intestinal gel for treatment of advanced Parkinson''s disease
(
- Contribution to journal › Scientific review
-
Mark
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?
(
- Contribution to journal › Article
-
Mark
Wirkung von Apomorphin auf nicht motorische Symptome bei Morbus Parkinson
(
- Contribution to journal › Scientific review
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Apomorphininjektionstherapie bei Morbus Parkinson
(
- Contribution to journal › Scientific review
-
Mark
Drug-related problems in Parkinson's disease: the role of community pharmacists in primary care
(
- Contribution to journal › Article
-
Mark
Parkinson's disease: The non-motor issues
(
- Contribution to journal › Scientific review
-
Mark
Apomorphin zur subkutanen Dauerinfusion bei fortgeschrittenem Morbus Parkinson: Effektivität, Verträglichkeit und Patientenzufriedenheit im Langzeitverlauf
(
- Contribution to journal › Scientific review
- 2010
-
Mark
The challenge of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Non-motor Symptoms Questionnaire and Scale for Parkinson's disease
(
- Contribution to journal › Article
- 2009
-
Mark
Dopamine replacement therapy in Parkinson´s Disease: past, present and future
2009) p.309-334(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2000
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
- 1997
-
Mark
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
- 1996
-
Mark
Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon
(
- Contribution to journal › Article
- 1995
-
Mark
Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
(
- Contribution to journal › Article
- 1994
-
Mark
Depression vanlig vid Parkinsons sjukdom. Begränsade studier kring symtom och behandling
(
- Contribution to journal › Article
- 1993
-
Mark
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture
(
- Contribution to journal › Article
-
Mark
Expression of platelet-derived growth factor in and around intrastriatal embryonic mesencephalic grafts
(
- Contribution to journal › Article
- 1986
-
Mark
Chemical characterization of cell-CAM 105, a cell-adhesion molecule isolated from rat liver membranes
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »